glp 1 kidney protection Potential kidney-protective and other effects of GLP-1 receptor GLP-1 receptor agonists, including semaglutide

MacIsaac RJ, Ekinci EI, Jerums G

The problem is that this system can become dysregulated

Key requirements

The maximum tolerable dose used in the study was higher for Zepbound (10-15 mg) compared to Wegovy (1.7-2.4 mg)

AstraZeneca and Pfizer compete by leveraging broad pharmaceutical portfolios, formulation expertise, and global distribution networks to advance GLP-1 pipelines with an emphasis on long-term safety, differentiated dosing regimens, and scalable home-use formats

At La Jolla Recovery, weve seen firsthand that lasting recovery requires addressing the underlying trauma, co-occurring mental health conditions, and behavioral patterns that drive substance use